Cutaneous malignant melanoma (CMM) is the most serious cutaneous malignancy. CMM
patients often develop an immune response to their tumours. Conflicting evidence suggests …

… Therefore, our results partially supported the hypothesis that MMP1 promoter SNPs might
have potential effects on melanoma progression and prognosis by influencing these clinical …

… of malignant melanoma (MM), as assessed by Breslow tumour thickness and polymorphisms
at … We now describe a new polymorphism in the promoter region upstream of the exon 1a …

… In cutaneous malignant melanoma (CMM), a number of studies have reported increased …
expression in metastatic melanoma. Tumour vascularity in metastatic melanoma has also been …

… on the MMP1 promoter activity in melanoma, breast cancer, … of the known MMP1 promoter
polymorphisms, we conducted a … common promoter SNPs in the MMP1 gene and risk of CM. …

… a role in the development and progression of melanoma (8). … gene, like single nucleotide
polymorphisms (SNPs) may alter … between VDR gene polymorphisms and melanoma risk and …

… In the Kaplan–Meier analysis, we observed that patients without the variant allele of the
polymorphism had poor melanoma-specific survival compared to those with the variant allele (p …

… for susceptibility to malignant melanoma. Accordingly, we aimed to examine the promoter
region and the 5′ end of the EGF gene to determine whether any polymorphisms exist in this …

… interferon-γ gene polymorphisms in melanoma patients. Melanoma Res 12:465–469,
2002 … to and prognostic markers in cutaneous malignant melanoma. Int J Cancer 107:673–675, …

… melanoma. In a small pilot case–control study, we found an association between three XPD
polymorphisms and melanoma … other NER gene polymorphisms with melanoma. Significant …